All In Biotech

Drugs by condition

Drugs approved for diabetic macular edema

Brand-name prescription drugs and biologics whose FDA label lists diabetic macular edema as an approved use. Matched on the label phrases: "diabetic macular edema".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

14

Still marketed, NDA or BLA

Drug classes

3

Novel drugs

4

New molecular entities and new biologics

In development

20

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for diabetic macular edema.

  • Pavblu (Aflibercept-Ayyh) · Amgen INC Oct 22, 2026
  • Enzeevu (Aflibercept-Abzv) · Sandoz INC Oct 22, 2026
  • Nufymco (Ranibizumab-Leyk) · Formycon AG Dec 18, 2025
  • Ahzantive (Aflibercept-Mrbb) · Formycon AG Jun 28, 2024
  • Yesafili (Aflibercept-Jbvf) · Biocon Biologics INC May 20, 2024

All approved drugs for diabetic macular edema, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 0 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Vascular Endothelial Growth Factor Inhibitor (9)

  • Eylea Aflibercept · Regeneron Pharmaceuticals · 2011
  • Lucentis Ranibizumab · Genentech · 2006
  • Pavblu Aflibercept-Ayyh · Amgen INC · 2026
  • Enzeevu Aflibercept-Abzv · Sandoz INC · 2026
  • Nufymco Ranibizumab-Leyk · Formycon AG · 2025
  • Yesafili Aflibercept-Jbvf · Biocon Biologics INC · 2024
  • Eylea Hd Aflibercept · Regeneron Pharmaceuticals · 2023
  • Cimerli Ranibizumab-Eqrn · Sandoz INC · 2022
  • Susvimo Ranibizumab · Genentech INC · 2021

Corticosteroid (2)

  • Iluvien Fluocinolone Acetonide · Alimera Sciences INC · 2014
  • Ozurdex Dexamethasone · Abbvie · 2009

Class not listed in FDA's data (3)

  • Vabysmo Faricimab-Svoa · Genentech INC · 2022
  • Beovu Brolucizumab-Dbll · Novartis Pharms Corp · 2019
  • Ahzantive Aflibercept-Mrbb · Formycon AG · 2024

Drugs in development for diabetic macular edema

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • 4D-1503E10 vg, eyePhase 35 trials

    4D Molecular Therapeutics · Neovascular Age-Related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration

  • TiespectusEYE201, MK-8748Phase 35 trials

    EyeBiotech Ltd. · Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization

  • EYP-1901Phase 34 trials

    EyePoint Pharmaceuticals, Inc. · Diabetic Macular Edema, DME, Diabetic Macular Edema (DME)

  • OLN324Phase 34 trials

    Ollin Biosciences, Inc. · Diabetic Macular Edema (DME), Wet Age Related Macular Degeneration, Wet Age-related Macular Degeneration

  • RemigromigEYE103, RestoretPhase 33 trials

    EyeBiotech Ltd. · Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO)

  • BAT5906Phase 32 trials

    Bio-Thera Solutions · Diabetic Macular Edema (DME), Neovascular (Wet) Age-related Macular Degeneration

  • OCS-01Phase 32 trials

    Oculis · Diabetic Macular Edema

  • Tabirafusp tedromerKSI-501Phase 32 trials

    Kodiak Sciences Inc · Diabetic Macular Edema (DME), Wet Age-related Macular Degeneration

  • AVT29proposed aflibercept HD biosimilarPhase 31 trial

    Alvotech Swiss AG · Diabetic Macular Edema

  • Roche (Genentech) · Diabetic Macular Edema

  • RC28-EPhase 31 trial

    RemeGen Co., Ltd. · Diabetic Macular Edema (DME), wAMD

  • BGE-102Phase 22 trials

    BioAge Labs, Inc. · Diabetic Macular Edema (DME), Obesity and Cardiovascular Risk

  • KHK4951Phase 22 trials

    Kyowa Kirin Co., Ltd. · Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD)

  • BI 3812465Phase 21 trial

    Boehringer Ingelheim · Diabetic Macular Edema

  • CU06-1004Phase 21 trial

    Curacle Co., Ltd. · DME, Diabetic Macular Edema, Diabetic Macular Edema (DME)

  • ENN0403Phase 21 trial

    EnnovaBio · Diabetic Macular Edema (DME)

  • INV-102Phase 21 trial

    Invirsa, Inc. · Non-center Involved Diabetic Macular Edema, Non-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy, Diabetic Retinopathy

  • OXU-001DEXAspheresPhase 21 trial

    Oxular Limited · Diabetic Macular Edema

  • RO7446603Phase 21 trial

    Roche (Genentech) · Diabetic Macular Edema

  • SNP318Phase 21 trial

    SciNeuro · Diabetic Macular Edema, DME

More on diabetic macular edema: recruiting trials · published research

Related in ophthalmology: Wet macular degeneration · Glaucoma · Dry eye disease · Geographic atrophy

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.